根据提交给美国证券交易委员会的Form 4文件显示，董事Blake Borgeson于2026年2月3日出售了220,000股 Recursion Pharmaceuticals Inc (NASDAQ:RXRX) ...

Recursion Pharmaceuticals Inc .股价触及52周低点，达到3.78美元，凸显了该公司面临的充满挑战的一年。根据 InvestingPro 数据，过去12个月，该股票经历了显著下跌，一年回报率为-46.12%。这一下跌反映了更广泛的市场条件和公司特定挑战，包括令人担忧的毛利率为-1152.34%和EBITDA为-6.3788亿美元，这些都影响了投资者情绪。随着这家生物技术 ...

It's a potential game-changing technology. The company just needs to prove to the world that it works well enough.

It might take a while for this AI company to prove its worth, if it ever does so.

Brings together Recursion’s scaled biology exploration and translational capabilities with Exscientia’s precision chemistry design and small molecule automated synthesis capabilities to create a ...

Monday - Friday, 6:00 - 7:00 PM ET In a Friday interview with CNBC's Jim Cramer, Recursion Pharmaceuticals CEO Chris Gibson discussed how his company is using artificial intelligence and machine ...

Management expressed confidence in achieving further milestones in 2025, supported by partnerships with Roche and Sanofi. CEO Gibson noted that the partnership milestones generated $45 million in cash ...

Nvidia’s forthright ambitions to expand its drug development footprint are coming into focus, with the global computing powerhouse announcing a trio of new initiatives including a new collaboration ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

Recursion Pharmaceuticals presents a compelling investment opportunity due to its AI-driven drug discovery platform, solid financials, and diverse pipeline, setting it apart from competitors like ...

Nvidia will help Recursion build a massive supercomputer. This will be used its for AI-driven drug discovery efforts. It may be the first of several moves to empower its platform. With the help of its ...

Investors with a lot of money to spend have taken a bearish stance on Recursion Pharmaceuticals (NASDAQ:RXRX). And retail traders should know. We noticed this today when the positions showed up on ...